E-LIB Suche - Ergebnisse für: Charlie W. Lees

1

Commentary on the Epidemiology of Inflammatory Bowel Diseas..:

Herauf, Michelle ; Coward, Stephanie ; Peña-Sánchez, Juan-Nicolás...
Gastroenterology. 166 (2024) 6 - p. 949-956 , 2024

2

Mechanisms and management of loss of response to anti-TNF t..:

Chanchlani, Neil ; Lin, Simeng ; Bewshea, Claire...
The Lancet Gastroenterology & Hepatology. 9 (2024) 6 - p. 521-538 , 2024

Link: https://doi.org/10.1016/..

3

Defining predictors of responsiveness to advanced therapies..:

Wyatt, Nicola J ; Watson, Hannah ; Anderson, Carl A...
BMJ Open. 14 (2024) 4 - p. e073639 , 2024

Link: https://doi.org/10.1136/..

4

Tu1848 INFLAMMATORY BOWEL DISEASE: A PHENOME-WIDE PRE- AND ..:

Ebert, Anthony C. ; Elmahdi, Rahma ; Poulsen, Gry...
Gastroenterology. 166 (2024) 5 - p. S-1434-S-1435 , 2024

Link: https://doi.org/10.1016/..

5

Tu1881 REAL-WORLD EFFECTIVENESS OF UPADACITINIB IN CROHN'S ..:

Elford, Alexander T. ; Bishara, Maria ; Plevris, Nikolas...
Gastroenterology. 166 (2024) 5 - p. S-1451-S-1452 , 2024

Link: https://doi.org/10.1016/..

6

Su1793 THE EFFECT OF ETRASIMOD ON FECAL CALPROTECTIN AND HI..:

Jairath, Vipul ; Rubin, David T. ; Verstockt, Bram...
Gastroenterology. 166 (2024) 5 - p. S-816 , 2024

Link: https://doi.org/10.1016/..

7

Real-world effectiveness of upadacitinib in Crohn's disease..:

Elford, Alexander Thomas ; Bishara, Maria ; Plevris, Nikolas...
Frontline Gastroenterology. 15 (2024) 4 - p. 297-304 , 2024

Link: https://doi.org/10.1136/..

8

The Effect of Etrasimod on Fecal Calprotectin and High-sens..:

Jairath, Vipul ; Rubin, David T ; Verstockt, Bram...
Inflammatory Bowel Diseases. , 2024

Link: https://doi.org/10.1093/..

9

Su1776 EFFICACY AND SAFETY OF ETRASIMOD AS A FIRST-LINE ADV..:

Sonnenberg, Elena ; Lees, Charlie W. ; Baert, Filip J....
Gastroenterology. 166 (2024) 5 - p. S-808 , 2024

Link: https://doi.org/10.1016/..

10

Tu1830 TOFACITINIB VERSUS VEDOLIZUMAB AMONG BIO-NAÏVE PATIE..:

Gros, Beatriz ; Constantine-Cooke, Nathan ; Kennedy, Jake...
Gastroenterology. 166 (2024) 5 - p. S-1426 , 2024

Link: https://doi.org/10.1016/..

11

Tu1854 REAL-WORLD EVIDENCE ON MEDICATION PATTERNS IN INFLAM..:

Christensen, Heidi ; Larsen, Lone ; Lees, Charlie W...
Gastroenterology. 166 (2024) 5 - p. S-1438-S-1439 , 2024

Link: https://doi.org/10.1016/..

12

Mo1764 INFLAMMATORY BOWEL DISEASE SUBGROUPS IDENTIFIED BY L..:

Constantine-Cooke, Nathan ; Monterrubio-Gómez, Karla ; Plevris, Nikolas...
Gastroenterology. 164 (2023) 6 - p. S-899 , 2023

Link: https://doi.org/10.1016/..

13

Validation of the ACE [Albumin, CRP, and Endoscopy] Index i..:

Grant, Rebecca K ; Jones, Gareth-Rhys ; Plevris, Nikolas...
Journal of Crohn's and Colitis. 18 (2023) 2 - p. 286-290 , 2023

Link: https://doi.org/10.1093/..

14

962 EARLY LIFE EXPOSURE TO PARENTAL CROHN'S DISEASE IS ASSO..:

Lee, Sun-Ho ; Qiu, Lanhui ; Olivera, Pablo A....
Gastroenterology. 164 (2023) 6 - p. S-213 , 2023

Link: https://doi.org/10.1016/..

15

Multiple infliximab biosimilar switches appear to be safe a..:

Gros, Beatriz ; Plevris, Nikolas ; Constantine‐Cooke, Nathan...
United European Gastroenterology Journal. 11 (2023) 2 - p. 179-188 , 2023

Link: https://doi.org/10.1002/..